D. Sirot

4.4k citations

89 papers · 3.8k indexed · h-index 37

Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 81
Endocrinology top 0.2%
- Vibrio bacteria research studies 13
- Enterobacteriaceae and Cronobacter Research 9
Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance 10
Pollution top 1%
- Pharmaceutical and Antibiotic Environmental Impacts 10
Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 28
Molecular Biology
- Bacterial biofilms and quorum sensing 21
Epidemiology
- Pneumonia and Respiratory Infections 11

Co-authors: J. Sirot Roger Labia C. Chanal Christophe de Champs Richard Bonnet R Cluzel A Petit El Bachir Chaibi
Cited by: Molecular Medicine Endocrinology Applied Microbiology and Biotechnology
Journals: Antimicrobial Agents and Chemotherapy (30 papers)Journal of Antimicrobial Chemotherapy (16 papers)Journal of Clinical Microbiology (4 papers)
Partner nations: France Denmark Luxembourg

In The Last Decade

D. Sirot

87 papers receiving 3.6k citations

Peers

Countries citing papers authored by D. Sirot

Since Specialization

Citations

This map shows the geographic impact of D. Sirot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sirot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sirot more than expected).

Fields of papers citing papers by D. Sirot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sirot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sirot. The network helps show where D. Sirot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Sirot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Sirot Line = papers co-authored together D. Sirot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 β-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5) Antimicrobial Agents and Chemotherapy ·Frédéric Robin,Julien Delmas,C. Chanal,D. Sirot,J. Sirot,Richard Bonnet	2005	26
2	Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiines Il Farmaco ·Frédéric Zentz,Roger Labia,D. Sirot,O. Faure,R. Grillot,Alain Valla	2005	17
3	Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study Journal of Antimicrobial Chemotherapy ·Christophe de Champs,C. Chanal,D. Sirot,شويکار سلامة,牧野歩実,Richard Bonnet,Nils Grote,L. C. Carosio,Dominicus Makukula,Angie Yineth Díaz Díaz,Timothy Andrew Mitchell,Aleksandra Snoch,MinKyung Ahn JongWoo Kim,Edhy Puerwandono,J. Sirot	2004	53
4	Impairment of Respiratory Burst in Polymorphonuclear Leukocytes by Extended-Spectrum Beta-Lactamase-Producing Strains of Klebsiella pneumoniae European Journal of Clinical Microbiology & Infectious Diseases ·Hany Sahly,Hazel M. Aucken,Vicente J. Benedí,Christiane Forestier,Vivian Fussing,Dennis Schrøder Hansen,Itzhak Ofek,Rainer Podschun,D. Sirot,Dorthe Sandvang,Edgar Saavedra,U. Ullmann	2004	19
5	Clinical relevance of Proteus mirabilis in hospital patients: a two year survey Journal of Antimicrobial Chemotherapy ·Christophe de Champs,Richard Bonnet,D. Sirot,C. Chanal,J. Sirot	2000	57
6	Bactericidal activity of three β-lactams alone or in combination with a β-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum β-lactamases Clinical Microbiology and Infection ·Micheline Roussel‐Delvallez,Florent Wallet,Anne Dao,María Josefa González Gómez,D. Sirot,G. Beaucaire,René Courcol	1998	8
7	Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae Journal of Antimicrobial Chemotherapy ·C. Chanal,D. Sirot,牧野歩実,Laurent Bret,J. Sirot	1996	51
8	Bactericidal effect of β-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum β-lactamase Journal of Antimicrobial Chemotherapy ·M. Roussel‐Delvallez,D. Sirot,Y. Berrouane,Mohamed Friha,丽张,F. Wallet,René Courcol	1995	9
9	Extended-spectrum plasmid-mediated -lactamases Journal of Antimicrobial Chemotherapy ·D. Sirot	1995	131
10	Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in Fran Journal of Antimicrobial Chemotherapy ·Cécile Henquell,D. Sirot,C. Chanal,Christophe de Champs,B. Santhosh Kumar,Tetsuo NAKAYA,Mark Feeney,J. Sirof,R Cluzel	1994	60
11	Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to β-lactamase inhibitors Journal of Antimicrobial Chemotherapy ·D. Sirot,C. Chanal,Cécile Henquell,Roger Labia,J. Sirot,R Cluzel	1994	34
12	Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a klebsiella pneumoniae producing an extended-spectrum β-lactamase Infection ·Christophe de Champs,D. Sirot,Marie Chanal,Iñigo Verdalet-Guzmán,D. Guélon,О Я Мезенова	1991	20
13	A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase Journal of Hospital Infection ·Christophe de Champs,G. Shyam,D. Guélon,J. Sirot,D. Sirot,D. Beytout,武文卿	1991	64
14	Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum β-lactamases TEM-4 and TEM-5 in Enterobacteriaceae Gene ·Wladimir Sougakoff,A Petit,Sylvie Goussard,D. Sirot,A Buré,Patrice Courvalin	1989	76
15	Interactions of meropenera, with -lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins Journal of Antimicrobial Chemotherapy ·Roger Labia,A Morand,陈晓明,D. Sirot,C. Chanal	1989	18
16	Klebsiella pneumoniae and Other Enterobacteriaceae Producing Novel Plasmid-Mediated -Lactamases Markedly Active Against Third-Generation Cephalosporins: Epidemiologic Studies Clinical Infectious Diseases ·J. Sirot,C. Chanal,A Petit,D. Sirot,Roger Labia,G Gerbaud	1988	144
17	Interactions of New Plasmid-Mediated -Lactamases with Third-Generation Cephalosporins Clinical Infectious Diseases ·Roger Labia,A Morand,Kiran Tiwari,J. Sirot,D. Sirot,A Petit	1988	48
18	Kinetic properties of two plasmid-mediated β-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins Journal of Antimicrobial Chemotherapy ·Roger Labia,A Morand,Kiran Tiwari,B. Dorney,D. Sirot,J. Sirot	1988	25
19	Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase Journal of Antimicrobial Chemotherapy ·D. Sirot,J. Sirot,Roger Labia,A Morand,Patrice Courvalin,Arlette Darfeuille–Michaud,KAY VAN MOL,R Cluzel	1987	294
20	Characterization of a β-lactamase from Pasteurella multocida Annales de l Institut Pasteur Microbiologie ·A. Philippon,B Joly,Dénis Reynaud,Paul Geertsema,J.L. Martel,D. Sirot,R Cluzel,P Névot	1986	15

About D. Sirot

D. Sirot is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Pharmacology and Pollution, having authored 89 papers that have together received 3.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (81 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers), Bacterial biofilms and quorum sensing (21 papers), Vibrio bacteria research studies (13 papers), Pneumonia and Respiratory Infections (11 papers), Antibiotic Use and Resistance (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers) and Enterobacteriaceae and Cronobacter Research (9 papers). The work is most often cited by research in Molecular Medicine (3.5k citations), Endocrinology (1.3k citations), Applied Microbiology and Biotechnology (470 citations), Pollution (766 citations) and Pharmacology (942 citations). D. Sirot has collaborated with scholars based in France, Denmark and Luxembourg. Frequent co-authors include J. Sirot, Roger Labia, C. Chanal, Christophe de Champs, Richard Bonnet, R Cluzel, A Petit, El Bachir Chaibi, Arlette Darfeuille–Michaud and A Morand. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology, Clinical Infectious Diseases and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact